<DOC>
	<DOCNO>NCT00231959</DOCNO>
	<brief_summary>This study evaluate effectiveness pramipexole ( Mirapex ) manage treatment-resistant depression .</brief_summary>
	<brief_title>Effectiveness Pramipexole Treatment-Resistant Depression</brief_title>
	<detailed_description>Depression serious medical illness , various type treatment develop . Both medication therapy proven effective treat depression . However , people depression benefit treatment . New medication need treat depression respond commonly used antidepressant . Pramipexole ( Mirapex ) often use treatment Parkinson 's disease , report antidepressant effect well . This study evaluate effectiveness pramipexole treat depression individual respond medication . Participants double blind study randomly assign receive either pramipexole placebo , addition current medication , 8 week . Treatment response assess end phase measure symptom depression . At time , individual respond treatment option continue 6-month follow-up study . Participants see monthly throughout 6 month assess treatment response . Participants exhibit response treatment tapered medication . All participant receive 3 month follow-up care , regardless response medication .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Meets diagnostic criterion major depressive disorder Meets criteria current major depressive episode Score least 18 MontgomeryAsberg Depression Rating Scale ( MADRS ) baseline visit Currently treat antidepressant monotherapy adequate dose 6 week willing enter open leadin treatment Agrees use effective form contraception throughout study Pregnant At risk suicide homicide Unstable medical illness ( e.g. , cardiovascular , liver , kidney , respiratory , endocrine , neurologic disease , include uncontrolled seizure disorder ) History substance use disorder within 6 month study enrollment History current psychotic feature Currently treat typical atypical antipsychotic medication Currently treat medication know significantly decrease pramipexole clearance ( e.g. , cimetidine , ranitidine , diltazem , verapamil , quinine triamterene ) Clinical laboratory evidence untreated hypothyroidism History 2week long course pramipexole Intolerance pramipexole dose Any investigational psychotropic drug use within last three month Level 3 great antidepressant resistance assess ATHF Three episode selfharm year prior study enrollment Documented history poor treatment adherence frequently miss appointment Parkinson 's disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Depression , Treatment-Resistant</keyword>
</DOC>